BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition

Rizwan Haq, Satoru Yokoyama, Elena B. Hawryluk, Göran B. Jönsson, Dennie Tompers Frederick, Kevin McHenry, Dale Porter, Thanh Nga Tran, Kevin T. Love, Robert Langer, Daniel G. Anderson, Levi A. Garraway, Lyn Mc Divitt Duncan, Donald L. Morton, Dave S.B. Hoon, Jennifer A. Wargo, Jun S. Song, David E. Fisher

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition'. Together they form a unique fingerprint.

Medicine & Life Sciences